Equity99 is bullish on IOL Chemicals & Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 175 in its research report dated April 13, 2018.
Equity99's research report on IOL Chemicals & Pharmaceuticals
Established in 1986, IOL Chemicals & Pharmaceuticals is India's one of the leading generic pharmaceutical company, and a significant player in the organic chemicals space. It has two business segments i.e. chemicals and pharmaceuticals. The chemical segment manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Acetyl Chloride and Mono Chloro acetic Acid (MCA), while under pharmaceuticals the company manufactures active pharmaceutical ingredient (APIs) i.e. Ibuprofen.
OutlookConsidering the above, along with the growth drivers; we recommend a strong BUY to our investors with a Target Price of Rs. 175 by 2020. We will closely monitor company's executions and keep upgrading our forecasts on the basis of earnings.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.